Necrotizing Ulcerative Gingivitis Treatment Market Share

  • Report ID: 3596
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Necrotizing Ulcerative Gingivitis Treatment Market Share

North American Market Forecast

The market share of necrotizing ulcerative gingivitis (NUG) treatment in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~32% by the end of 2035. The growth of the market can be attributed majorly to the increasing prevalence of oral diseases in developed countries, including the US, backed by poor diet, and high cases of diabetes amongst the people. According to the data from the Centers for Disease Control and Prevention (CDC), more than 1 in every 4 adults, i.e., around 26% of the American population suffers from untreated tooth decay. Moreover, growing health awareness amongst the people and government initiatives to ensure efficient healthcare facilities, are estimated to boost the market growth. Besides this, the rising focus on the advancements in the diagnosis and treatment of different necrotizing gingivostomatitis diseases is also expected to drive market growth. The lack of pure drinking water which contains fluoride or other chemicals leads to teeth disorders and gum diseases thereby rises the chances of necrotizing ulcerative gingivitis and the growth of the market.

APAC Market Statistics

The Asia Pacific necrotizing ulcerative gingivitis (NUG) treatment market is estimated to be the second largest, registering a share of about ~28% by the end of 2035. The growth of the market can be attributed to improving the public healthcare system, and growing awareness among people regarding oral hygiene. The increasing population across the region with stress, anxiety, and sleep disorders is estimated to drive market growth across the world. Education about healthy eating habits and mouth rising regularly twice a day or after each meal if required is estimated to reduce the occurrence of necrotizing ulcerative gingivitis disease. The increasing disposable income of people and living standards are changing the eating and drinking habits of people across the region which cause oral issues. Binge drinking of alcohol and regular consumption of tobacco is one of the major reasons for oral issues. The escalating use of antibiotics, ointments, topical pain relief, and solutions for oral health is estimated to drive market growth.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a share of 22% by the end of 2035. The growth of the market can be attributed majorly to the increasing preference for oral health across the region. The growing number of hospitals and rising education programs to prevent the drinking of fluoride water are estimated to boost market growth. The increasing number of people suffering from insomnia owing to work and family stress is rising the risk of gingivitis disease. The poor availability of nutritional diets and lack of proper food supply in underdeveloped countries of the region are also anticipated to drive market growth in the coming years. The negligence among people regarding oral health and ignoring issues such as tooth damage, loose teeth, tooth decay, and formation of plaque is expected to propel the growth of the market in this region.

Research Nester
Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3596
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of oral diseases, and poor diet and dental hygiene are the major factors driving the market growth.

The market size of necrotizing ulcerative gingivitis (NUG) treatment is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2035.

Lack of health awareness amongst people and discomfort during treatment procedures are estimated to be the growth hindering factors for the market expansion

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, distribution channel, and by region.

The medication segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying